Search Results - "Seminars in thrombosis and hemostasis"

Refine Results
  1. 1

    COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies by Di Minno, Alessandro, Ambrosino, Pasquale, Calcaterra, Ilenia, Di Minno, Matteo Nicola Dario

    Published in Seminars in thrombosis and hemostasis (01-10-2020)
    “…Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations, leading in some cases to a critical condition with poor long-term…”
    Get more information
    Journal Article
  2. 2

    Next-Generation Sequencing and Emerging Technologies by Kumar, Kishore R, Cowley, Mark J, Davis, Ryan L

    Published in Seminars in thrombosis and hemostasis (01-10-2019)
    “…Genetic sequencing technologies are evolving at a rapid pace with major implications for research and clinical practice. In this review, the authors provide an…”
    Get more information
    Journal Article
  3. 3

    Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation by Thomas, James, Kostousov, Vadim, Teruya, Jun

    Published in Seminars in thrombosis and hemostasis (01-02-2018)
    “…Extracorporeal membrane oxygenation (ECMO) has been used for >40 years to support lung and heart failure; however, bleeding and thrombosis remain serious…”
    Get more information
    Journal Article
  4. 4

    Platelet Physiology by Gremmel, Thomas, Frelinger, 3rd, Andrew L, Michelson, Alan D

    Published in Seminars in thrombosis and hemostasis (01-04-2016)
    “…Platelets are the smallest blood cells, numbering 150 to 350 × 10(9)/L in healthy individuals. The ability of activated platelets to adhere to an injured…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1) by Morrow, Gael B, Mutch, Nicola J

    Published in Seminars in thrombosis and hemostasis (01-04-2023)
    “…Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its regulation of fibrinolysis. However, it is now known that this…”
    Get more information
    Journal Article
  8. 8

    The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis by Flevaris, Panagiotis, Vaughan, Douglas

    Published in Seminars in thrombosis and hemostasis (01-03-2017)
    “…Extracellular matrix (ECM) deposition during wound healing is a physiological response to an insult. Wound healing becomes deregulated in the setting of…”
    Get more information
    Journal Article
  9. 9

    Environmental and Genetic Risk Factors Associated with Venous Thromboembolism by Crous-Bou, Marta, Harrington, Laura B, Kabrhel, Christopher

    Published in Seminars in thrombosis and hemostasis (01-11-2016)
    “…Venous thromboembolism (VTE) includes deep vein thrombosis and pulmonary embolism, and a combination of environmental and genetic risk factors contributes to…”
    Get more information
    Journal Article
  10. 10

    Congenital fibrinogen disorders: an update by de Moerloose, Philippe, Casini, Alessandro, Neerman-Arbez, Marguerite

    Published in Seminars in thrombosis and hemostasis (01-09-2013)
    “…Hereditary fibrinogen abnormalities comprise two classes of plasma fibrinogen defects: Type I, afibrinogenemia or hypofibrinogenemia, which has absent or low…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Thrombin: A Pivotal Player in Hemostasis and Beyond by Larsen, Julie Brogaard, Hvas, Anne-Mette

    Published in Seminars in thrombosis and hemostasis (01-10-2021)
    “…The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by converting fibrinogen to fibrin and activating coagulation factor…”
    Get more information
    Journal Article
  13. 13

    Factor XII Contact Activation by Naudin, Clément, Burillo, Elena, Blankenberg, Stefan, Butler, Lynn, Renné, Thomas

    Published in Seminars in thrombosis and hemostasis (01-11-2017)
    “…Contact activation is the surface-induced conversion of factor XII (FXII) zymogen to the serine protease FXIIa. Blood-circulating FXII binds to negatively…”
    Get more information
    Journal Article
  14. 14
  15. 15

    COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? by Favaloro, Emmanuel J, Henry, Brandon Michael, Lippi, Giuseppe

    Published in Seminars in thrombosis and hemostasis (01-02-2022)
    “…Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably…”
    Get more information
    Journal Article
  16. 16

    NETosis: a new factor in tumor progression and cancer-associated thrombosis by Demers, Melanie, Wagner, Denisa D

    Published in Seminars in thrombosis and hemostasis (01-04-2014)
    “…Neutrophils have long been known as innate immune cells that phagocytose and kill pathogens and mount inflammatory responses protecting the host from…”
    Get more information
    Journal Article
  17. 17

    Platelet Activation and Thrombosis in COVID-19 by Iba, Toshiaki, Wada, Hideo, Levy, Jerrold H

    Published in Seminars in thrombosis and hemostasis (01-02-2023)
    “…Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated with COVID-19 has unique characteristics. Compared with bacterial…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis by Turner, Simone, Naidoo, Caitlin A, Usher, Thomas J, Kruger, Arneaux, Venter, Chantelle, Laubscher, Gert J, Khan, M Asad, Kell, Douglas B, Pretorius, Etheresia

    Published in Seminars in thrombosis and hemostasis (01-03-2024)
    “…The prevailing hypotheses for the persistent symptoms of Long COVID have been narrowed down to immune dysregulation and autoantibodies, widespread organ…”
    Get more information
    Journal Article
  20. 20

    The Role of Fibrin(ogen) in Wound Healing and Infection Control by Kearney, Katherine J, Ariëns, Robert A S, Macrae, Fraser L

    Published in Seminars in thrombosis and hemostasis (01-03-2022)
    “…Fibrinogen, one of the most abundant plasma proteins playing a key role in hemostasis, is an important modulator of wound healing and host defense against…”
    Get more information
    Journal Article